Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers

Fig. 2

An analysis of transcriptional profiles and KEGG pathway enrichments in COVID-19 vs. healthy PBMNCs along with TMPRSS2high versus TMPRSS2low MCF-7 and EA.Hy926 cells were conducted using RNA sequencing. A: A Volcano plot depicts the differentially expressed genes (DEGs) between COVID-19 and healthy blood samples (COVID19db). Genes that are significantly downregulated are indicated in dark blue, while significantly upregulated genes are shown in red and non-significantly regulated genes are represented in grey. B: The top 10 enriched KEGG pathways from the upregulated genes between COVID-19 and healthy blood samples are presented. C, D: The top 20 enriched KEGG terms derived from the upregulated genes of TMPRSS2high versus TMPRSS2low MCF-7 (C) and EA.Hy926 (D) cells are displayed. The enriched GO terms found in both TMPRSS2high and COVID-19 are highlighted with green circles. E: Correlation plots illustrate the commonly upregulated genes in the two most enriched KEGG pathways concerning TMPRSS2 expression from blood samples of COVID-19 patients (COVID19db). The gene expressions of OAS1, STAT1 and IRF7 are exemplified here

Back to article page